Cancer Patients' Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy: A Clinical Waitlist Control Study.
Age effect
Cancer
EORTC QLQ-C30
Neurofeedback
Quality of life
Self-efficacy
Journal
Applied psychophysiology and biofeedback
ISSN: 1573-3270
Titre abrégé: Appl Psychophysiol Biofeedback
Pays: Germany
ID NLM: 9712383
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
accepted:
04
11
2022
medline:
22
5
2023
pubmed:
20
11
2022
entrez:
19
11
2022
Statut:
ppublish
Résumé
Electroencephalographic neurofeedback (EEG NF) can improve quality of life (QoL) and reduce distress by modifying the amplitude of selected brain frequencies. This study aims to investigate the effects of NF therapy on QoL and self-efficacy in cancer patients and to explore age-related reactions. In a waitlist control paradigm, psychometric data (EORTC QLQ-C30, General Self-Efficacy Scale) of 20 patients were collected at three different time points, each five weeks apart. An outpatient 10-session NF intervention (mobile) was conducted between the second and third measurement point. QoL and self-efficacy changed significantly over time (QoL: F(2,36) = 5.294, p < .05, η
Identifiants
pubmed: 36401150
doi: 10.1007/s10484-022-09571-1
pii: 10.1007/s10484-022-09571-1
pmc: PMC9676905
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
217-227Informations de copyright
© 2022. The Author(s).
Références
Eur J Cardiothorac Surg. 2017 Jan;51(1):148-154
pubmed: 27506669
J Cancer Surviv. 2015 Mar;9(1):11-9
pubmed: 25028218
J Consult Clin Psychol. 1995 Dec;63(6):981-6
pubmed: 8543720
J Natl Cancer Inst Monogr. 1994;(16):191-7
pubmed: 7999464
Cancer. 2014 Aug 1;120(15):2237-46
pubmed: 24891116
J Pain Symptom Manage. 2018 May;55(5):1276-1285
pubmed: 29421164
Breast. 2007 Jun;16(3):241-51
pubmed: 17236771
Psychooncology. 2017 Nov;26(11):1922-1928
pubmed: 28233366
Basic Clin Neurosci. 2016 Apr;7(2):143-58
pubmed: 27303609
Eur J Cancer. 2004 Mar;40(5):673-80
pubmed: 15010067
Cancer. 2005 Jan 15;103(2):377-82
pubmed: 15558809
Psychiatr Pol. 2017 Dec 30;51(6):1095-1106
pubmed: 29432505
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419832361
pubmed: 30832518
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Health Psychol. 1997 Mar;16(2):163-70
pubmed: 9269887
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Cancer. 2017 Jun 1;123(11):1989-1997
pubmed: 28257146
Cancer. 1999 Nov 1;86(9):1768-74
pubmed: 10547550
Ann Transl Med. 2018 Feb;6(4):84
pubmed: 29666807
Brain. 2020 Jun 1;143(6):1674-1685
pubmed: 32176800
Oncotarget. 2017 May 30;8(22):36800-36811
pubmed: 28404938
J Clin Oncol. 2004 May 15;22(10):1849-56
pubmed: 15143077
Psychooncology. 2000 Mar-Apr;9(2):137-46
pubmed: 10767751
Qual Life Res. 2010 Apr;19(3):351-61
pubmed: 20146007
Qual Life Res. 2010 Aug;19(6):827-36
pubmed: 20401551
Integr Cancer Ther. 2015 Jul;14(4):318-40
pubmed: 25716351
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7645-50
pubmed: 10852953
Neurosci Lett. 2003 Apr 3;340(1):17-20
pubmed: 12648748
Cancer Nurs. 2009 Sep-Oct;32(5):347-56; quiz 357-8
pubmed: 19661800
Int J Psychophysiol. 1997 Jun;26(1-3):31-49
pubmed: 9202993
Oncologist. 2002;7(2):120-5
pubmed: 11961195
Integr Cancer Ther. 2013 Nov;12(6):475-87
pubmed: 23584550
Neurophysiol Clin. 2015 Dec;45(6):423-33
pubmed: 26553293
Psychooncology. 2011 Oct;20(10):1084-91
pubmed: 20672245
Neurosci Biobehav Rev. 2015 Jul;54:29-37
pubmed: 25862940
Int J Behav Med. 2020 Aug;27(4):357-365
pubmed: 32394220
Integr Cancer Ther. 2014 Jan;13(1):30-7
pubmed: 23439659